世界の次世代シーケンシング（NGS）市場
Market Size in USD Billion
CAGR :
% 
 予測期間 |
2024 –2031 |
 市場規模（基準年） |
USD 13.88 Billion |
 Market Size (Forecast Year) |
USD 40.78 Billion |
 CAGR |
% |
| Major Markets Players |
|
>世界の次世代シーケンシング（NGS）市場、製品とサービス別（消耗品、サービス、機器）、テクノロジー別（合成によるシーケンシング（SBS）、ライゲーションによるシーケンシング（SBL）、その他）、アプリケーション別（製薬微生物学、薬物とバイオマーカーの発見、診断、精密医療、農業と動物の研究、食品病原体スクリーニング、その他）、エンドユーザー別（製薬およびバイオテクノロジー企業、学術研究機関、病院と診療所、臨床検査室、契約研究機関（CROS）、その他）、流通チャネル別（直接入札、小売販売、その他） - 2031年までの業界動向と予測。
次世代シーケンシング（NGS）市場分析と規模
次世代シーケンシング (NGS) の世界市場は、パーソナライズ医療の需要の高まりと、臨床診断および研究アプリケーションにおける NGS 技術の採用の増加によって牽引されています。ただし、市場の成長に対する制約の 1 つは、NGS 手順に関連するコストの高さであり、発展途上地域でのアクセスが制限されています。この市場におけるチャンスは、改善されたデータ分析ツールやより高速なシーケンシング プラットフォームなど、シーケンシング プロセスの効率と精度を高めることができる NGS 技術の進歩にあります。1 つの課題は、さまざまな研究所や医療現場で一貫性と信頼性を確保するために、NGS ベースのテストの標準化されたプロトコルと規制が必要であることです。
データブリッジマーケットリサーチは、世界の次世代シーケンシング（NGS）市場は2024年から2031年の予測期間に15.1％のCAGRで成長し、2023年の138億8,000万米ドルから2031年には407億8,000万米ドルに達すると分析しています。
|
レポートメトリック |
詳細 |
|
予測期間 |
2024年から2031年 |
|
基準年 |
2023 |
|
歴史的な年 |
2022 (カスタマイズ可能 2016-2021) |
|
定量単位 |
収益（10億米ドル） |
|
対象セグメント |
製品とサービス（消耗品、サービス、機器）、テクノロジー（合成によるシーケンシング（SBS）、ライゲーションによるシーケンシング（SBL）、その他）、アプリケーション（製薬微生物学、薬物およびバイオマーカーの発見、診断、精密医療、農業および動物研究、食品病原体スクリーニング、その他）、エンドユーザー（製薬およびバイオテクノロジー企業、学術および研究機関、病院および診療所、臨床検査室、開発業務受託機関（CROS）、その他）、流通チャネル（直接入札、小売販売、その他） |
|
対象国 |
米国、カナダ、メキシコ、英国、ドイツ、フランス、スペイン、イタリア、ベルギー、ロシア、スイス、オランダ、トルコ、その他のヨーロッパ諸国、中国、オーストラリア、日本、インド、シンガポール、韓国、マレーシア、タイ、インドネシア、フィリピン、その他のアジア太平洋諸国、ブラジル、アルゼンチン、その他の南米諸国、南アフリカ、エジプト、サウジアラビア、UAE、イスラエル、その他の中東およびアフリカ諸国 |
|
対象となる市場プレーヤー |
Illumina, Inc.、Thermo Fisher Scientific Inc.、QIAGEN、Merck KGaA、Charles River Laboratories、Revvity、Promega Corporation.、Agilent Technologies, Inc.、Takara Bio Inc.、Eurofins Scientific、Hamilton Company、BGI、Azenta US, Inc.、Beckman Coulter, Inc.、Bio-Rad Laboratories, Inc.、PacBio.、Macrogen, Inc.、Gilson Incorporated、New England Biolabs、Oxford Nanopore Technologies plc.、LGC Biosearch Technologies、PCR Biosystems、ACT Genomics、Quantabio、DNASTAR、NimaGen など |
市場の定義
次世代シーケンシング (NGS) は、ハイスループット シーケンシングとも呼ばれ、DNA と RNA を迅速にシーケンシングするために使用される強力なテクノロジーです。従来のサンガー シーケンシングは速度が遅く、コストもかかりますが、NGS では数百万の DNA 断片を同時にシーケンシングできるため、研究者は大規模なゲノムを迅速かつ効率的に分析し、遺伝子変異を特定し、遺伝子発現パターンを研究することができます。NGS はゲノム研究に革命をもたらし、疾患の遺伝的基礎、微生物群集の多様性、種の進化に関する新たな視点を可能にしました。
世界の次世代シーケンシング（NGS）市場の動向
このセクションでは、市場の推進要因、利点、機会、制約、課題について理解します。これらはすべて、以下のように詳細に説明されます。
ドライバー
- ゲノムに焦点を当てた薬理学の採用の増加
ゲノム薬理学の採用増加は、次世代シーケンシング（NGS）の世界市場における主要な推進力として機能し、個別化医療と標的療法の状況を変えています。医療提供者が個々の遺伝子プロファイルに基づいて治療をカスタマイズすることの価値を認識するにつれて、ハイスループットで正確なゲノムシーケンシングの需要が急増しています。NGSテクノロジーは患者のゲノムの包括的な分析を可能にし、薬物反応、耐性、および潜在的な副作用に影響を与える遺伝子変異を正確に特定できます。このレベルの個別化された洞察は、臨床医が各患者に最も効果的で安全な治療を選択するのを導き、結果を改善し、試行錯誤の処方を減らします。その結果、さまざまな医療分野でのゲノム薬理学の採用増加と、患者のケアと結果に革命をもたらす可能性に後押しされて、NGS市場は急速に拡大しています。
- 大手企業が提供する幅広い製品ポートフォリオ
市場プレーヤーが提供する幅広い製品ポートフォリオは、多様な研究および臨床ニーズを満たす包括的なさまざまなソリューションを顧客に提供するため、世界の次世代シーケンシング (NGS) 市場の成長の重要な原動力となっています。さまざまな NGS プラットフォーム、消耗品、ソフトウェアを提供することで、市場プレーヤーはさまざまなレベルの研究の複雑さ、スループット要件、予算の制約に対応できます。この汎用性により、研究者や臨床医は、全ゲノムシーケンシング、ターゲットシーケンシング、トランスクリプトーム分析など、特定のアプリケーションに最も適したツールを選択できます。さらに、幅広いポートフォリオには、がんゲノミクス、マイクロバイオーム研究、希少疾患研究用のキットなどの専門的な製品を含めることができ、学術界、医療、産業界の幅広い顧客にとってさらに魅力的です。
機会
- NGS技術の進歩
シーケンス速度、精度、拡張性、費用対効果の向上により、NGSの用途はゲノミクス、腫瘍学、感染症などのさまざまな分野で大幅に拡大しました。この用途の拡大により、NGS技術の需要が高まっただけでなく、新しい市場も開拓されました。さらに、シーケンスのコストが低下したことで、研究者、臨床医、患者にとってNGSがより身近なものとなり、臨床診断や個別化医療への導入がさらに促進されました。さらに、ロングリードシーケンス技術やポータブルシーケンスデバイスの開発などの進行中の技術革新により、NGSプラットフォームのパフォーマンスと使いやすさが回復し続け、顧客に対する価値提案が強化されています。
抑制/挑戦
- 臨床検査室におけるNGS導入の複雑さ
臨床検査室における次世代シーケンシング (NGS) の導入には、NGS 市場の成長を妨げるいくつかの制約があります。大きな制約の 1 つは、NGS データの複雑さと変動性です。生成される膨大な量の遺伝子データを分析および解釈するには、高度なバイオインフォマティクス ツールが必要です。臨床検査室は、正確で実用的な結果を確実に得るために、これらのリソースと熟練した人員に投資する必要がありますが、これが導入の障壁となる可能性があります。もう 1 つの制約は、NGS 用の高度な機器と特殊な装置の需要です。これらの機器は高価になる可能性があり、維持するにはインフラストラクチャと専門知識への多大な投資が必要です。小規模の臨床検査室では、これらの投資コストを正当化するのに苦労し、NGS の広範な導入が制限される可能性があります。
最近の動向
- 2024年4月、メルクKGaAは業界初のオールインワンの検証済み遺伝子安定性アッセイを導入しました。Aptegra CHO遺伝子安定性アッセイは、全ゲノム配列解析とバイオインフォマティクスを使用して、クライアントのバイオセーフティテストを迅速化し、商業生産への移行を促進します。このイノベーションにより、メルクKGaAはクライアントのバイオセーフティテストを合理化し、商業生産への移行を迅速化し、市場での競争力を高めることができます。
- 2024年1月、QIAGENはQIAGEN CLC Genomics Workbench PremiumをLightSpeedテクノロジーでアップグレードし、体細胞癌の二次解析における次世代シーケンシング（NGS）のサポートを追加しました。このソフトウェアアクセラレータは、FASTQファイルの生のシーケンシングデータを、驚くほど低コストかつ高速に、VCFファイル内の解釈可能な遺伝子変異リストに効率的に変換します。このアップグレードにより、QIAGENの提供が強化され、体細胞癌のNGS解析のためのより高速でコスト効率の高いソリューションが顧客に提供され、競争力が向上します。
- 2024年1月、ベックマン・コールター社は、持続可能な研究室ソリューションの先駆者であるポリカルビン社と提携しました。両社は、液体処理自動化プラスチックの研究室の持続可能性に革命を起こすことを目指しています。このコラボレーションは、ベックマン・コールターライフサイエンスの自動液体処理の専門知識とポリカルビンの循環型経済プラットフォームを融合し、研究室用プラスチックの持続可能性に焦点を当てています。
- 2023年11月、QIAGENとDNA Labs Internationalは、QIAGENの法医学遺伝子系譜学用ForenSeq KintelligenceシステムとGEDmatch PROデータベースを組み合わせて、20年前の未解決事件の解決に協力しました。これは、このアプローチが人間識別に有効であり、採用が増えていることを浮き彫りにしています。これにより、QIAGENの法医学遺伝子系譜学ソリューションの有効性が高まり、法医学市場での採用と売上が増加する可能性があります。
- 2023年11月、ベックマン・コールター社は、独自のSLIMamp技術を使用したIVDおよびRUO NGS検査ソリューションの開発および販売業者であるピラーバイオサイエンス社と協力契約を締結しました。契約の一環として、ピラーバイオサイエンス社は、Biomek NGeniuS次世代ライブラリー調製システムで使用するための一連のアプリケーションを作成します。この協力により、ピラーバイオサイエンス社の高度なNGS検査ソリューションを統合することでベックマン・コールター社の製品が強化され、がん患者はより正確な治療法の選択が可能となります。
- 2023年11月、QIAGENとElement Biosciences, Inc.は、革新的なシーケンシングプラットフォームであるElement AVITI Systemに包括的な次世代シーケンシング（NGS）ワークフローを提供するための戦略的パートナーシップを発表しました。このパートナーシップにより、QIAGENのNGSワークフローのポートフォリオが拡大し、ゲノミクス市場における地位が強化されます。
- 2023年10月、ベックマン・コールター社と10x Genomicsは、シングルセルアッセイワークフローの自動化ソリューションを強化するために提携しました。このコラボレーションでは、10x Genomicsは、ベックマン・コールター・ライフサイエンスのBiomek i7自動液体ハンドラーで使用するためにカスタマイズされたChromiumシングルセルキットを開発します。このカスタマイズされたアプリケーションは、10x Genomicsのシングルセルライブラリの準備を自動化し、シーケンスの準備が整った完成したライブラリの高品質で大規模な生産を保証することを目的としています。このパートナーシップにより、ベックマン・コールターはシングルセルアッセイの強化された自動化ソリューションを提供でき、顧客に合理化されたワークフローと改善された効率を提供します。
- 2023年10月、Azenta US, Inc.は、Azenta Life SciencesのGENEWIZマルチオミクスおよび合成ソリューションが2023年11月6日から10日までGENEWIZウィークを主催すると発表しました。このイベントには、バーチャルワークショップ、プロモーション、ゲノム研究の卓越性のための助成金プログラムが含まれます。GENEWIZウィークの開催により、Azentaのブランド認知度が向上し、新規顧客が集まり、ゲノム研究コミュニティでのコラボレーションが促進され、最終的には成長とイノベーションが促進されます。
- 2023年9月、チャールズリバーラボラトリーズとバイオ医薬品向け次世代シーケンシング（NGS）検査サービスを提供するPathoQuest SASは、共同で画期的な研究をワクチン誌に発表したことを発表しました。この研究では、PathoQuest独自の適正製造基準（GMP）グレードのNGSベースの検査が、生体内検査と比較してウイルス汚染物質の検出能力に優れていることが強調されました。この成果により、同社の評判が向上し、バイオ医薬品検査のリーダーとしての地位が確立され、高度で信頼性の高い検査ソリューションを求めるより多くの顧客を引き付ける可能性があります。
- 2023年5月、チャールズリバーラボラトリーズは、細菌同定および真菌同定のためのアキュジェニックス次世代シーケンシング（アキュジェニックスNGS）を導入しました。この技術は、サンプルから数百万の個々のDNA断片を配列し、医薬品およびパーソナルケアメーカーに重要な微生物管理情報を提供します。この新しい技術は同社のサービスを強化し、医薬品およびパーソナルケアメーカーに製品の品質と規制遵守を向上させる高度な微生物管理ソリューションを提供します。
世界の次世代シーケンシング（NGS）市場の範囲
世界の次世代シーケンシング (NGS) 市場は、製品とサービス、テクノロジー、アプリケーション、エンド ユーザー、流通チャネルに基づいて 5 つの主要なセグメントに分割されています。セグメント間の成長は、ニッチな成長分野と市場にアプローチするための戦略を分析し、コア アプリケーション領域とターゲット市場の違いを判断するのに役立ちます。
製品とサービス
- 消耗品
- サービス
- 楽器
製品とサービスに基づいて、世界の次世代シーケンシング (NGS) 市場は、消耗品、サービス、機器に分類されます。
テクノロジー
- シーケンシングバイシンセシス（SBS）
- ライゲーションによるシーケンシング（SBL）
- その他
技術に基づいて、世界の次世代シーケンシング (NGS) 市場は、合成によるシーケンシング (SBS)、ライゲーションによるシーケンシング (SBL)、その他に分類されます。
応用
- 医薬品微生物学
- 医薬品およびバイオマーカーの発見
- 診断
- 精密医療
- 農業および動物研究
- 食品病原菌検査
- その他
アプリケーションに基づいて、世界の次世代シーケンシング (NGS) 市場は、医薬品微生物学、薬物およびバイオマーカーの発見、診断、精密医療、農業および動物研究、食品病原体スクリーニング、その他に分類されます。
エンドユーザー
- 製薬・バイオテクノロジー企業
- 学術研究機関
- 病院・クリニック
- 臨床検査室
- 契約研究機関 (CROS)
- その他
エンドユーザーに基づいて、世界の次世代シーケンシング (NGS) 市場は、製薬およびバイオテクノロジー企業、学術および研究機関、病院および診療所、臨床検査室、契約研究機関 (CROS)、その他に分類されます。
流通チャネル
- 直接入札
- 小売販売
- その他
流通チャネルに基づいて、世界の次世代シーケンシング (NGS) 市場は、直接入札、小売販売、その他に分類されます。
世界の次世代シーケンシング（NGS）市場の地域分析/洞察
世界の次世代シーケンシング (NGS) 市場が分析され、上記の製品とサービス、テクノロジー、アプリケーション、エンド ユーザー、流通チャネルに基づいて市場規模の洞察と傾向が提供されます。
この世界的な次世代シーケンシング (NGS) 市場レポートで取り上げられている国は、米国、カナダ、メキシコ、英国、ドイツ、フランス、スペイン、イタリア、ベルギー、ロシア、スイス、オランダ、トルコ、その他のヨーロッパ諸国、中国、オーストラリア、日本、インド、シンガポール、韓国、マレーシア、タイ、インドネシア、フィリピン、その他のアジア太平洋諸国、ブラジル、アルゼンチン、その他の南米諸国、南アフリカ、エジプト、サウジアラビア、UAE、イスラエル、その他の中東およびアフリカ諸国です。
北米は、多数の主要市場プレーヤーの存在、研究および臨床アプリケーションにおける NGS 技術の採用率の高さ、ゲノミクス研究を支援する政府の好ましい取り組みと資金提供などの要因により、世界の次世代シーケンシング (NGS) 市場を支配すると予想されています。
米国は、多数の NGS 技術プロバイダーの存在、ゲノム研究への多額の投資、臨床および研究の現場での NGS の採用を促進する支援的な規制環境などの要因により、北米の次世代シーケンシング (NGS) 市場で優位に立つと予想されています。
英国は、先進的な医療インフラ、ゲノム研究に対する強力な政府支援、そして NGS 技術とサービスの確立された市場により、ヨーロッパの次世代シーケンシング (NGS) 市場で優位に立つと予想されています。
中国は、人口の多さ、精密医療の導入増加、ゲノミクス研究を推進する政府の取り組み、同地域におけるNGS技術プロバイダーの増加により、アジア太平洋地域の次世代シーケンシング（NGS）市場で優位に立つと予想されています。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える個別の市場影響要因と市場規制の変更も提供しています。下流および上流のバリュー チェーン分析、技術動向、ポーターの 5 つの力の分析、ケース スタディなどのデータ ポイントは、個々の国の市場シナリオを予測するために使用される指標の一部です。また、国別データの予測分析を提供する際には、グローバル ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面する課題、国内関税と貿易ルートの影響も考慮されます。
競争環境と世界の次世代シーケンシング（NGS）市場シェア分析
グローバル次世代シーケンシング (NGS) 市場の競争状況では、競合他社ごとに詳細が提供されます。詳細には、企業概要、企業財務、収益、市場の可能性、研究開発への投資、新規市場への取り組み、グローバルなプレゼンス、生産拠点と施設、生産能力、企業の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性が含まれます。上記のデータ ポイントは、グローバル次世代シーケンシング (NGS) 市場における企業の重点にのみ関連しています。
世界の次世代シーケンシング（NGS）市場で活動している主要企業には、Illumina, Inc.、Thermo Fisher Scientific Inc.、QIAGEN、Merck KGaA、Charles River Laboratories、Revvity、Promega Corporation.、Agilent Technologies, Inc.、Takara Bio Inc.、Eurofins Scientific、Hamilton Company、BGI、Azenta US, Inc.、Beckman Coulter, Inc.、Bio-Rad Laboratories, Inc.、PacBio.、Macrogen, Inc.、Gilson Incorporated、New England Biolabs、Oxford Nanopore Technologies plc.、LGC Biosearch Technologies、PCR Biosystems、ACT Genomics、Quantabio、DNASTAR、NimaGen. などがあります。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS FIVE FORCES
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASE IN THE ADOPTION OF GENOME-FOCUSED PHARMACOLOGY
5.1.2 WIDE PRODUCT PORTFOLIO OFFERED BY MAJOR PLAYERS
5.1.3 USE OF NEXT GENERATION SEQUENCING IN DRUG DEVELOPMENT
5.1.4 INCREASE TREND TOWARDS PERSONALIZED MEDICATION
5.2 RESTRAINTS
5.2.1 HIGH COST OF INSTALLATION AND MAINTENANCE OF EQUIPMENT’S IN THE LABORATORY
5.2.2 COMPLEXITY DURING IMPLEMENTATION OF NGS IN THE CLINICAL LAB
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYERS
5.3.2 INCREASING ADVANCEMENT IN NGS TECHNOLOGY
5.3.3 INCREASING APPLICATIONS OF NGS IN CLINICAL DIAGNOSTICS
5.4 CHALLENGES
5.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM NGS
5.4.2 DATA PRIVACY AND SECURITY
6 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT AND SERVICE
6.1 OVERVIEW
6.2 CONSUMABLES
6.2.1 LIBRARY PREPARATION CONSUMABLES
6.2.2 SAMPLE PREPARATION CONSUMABLES
6.3 SERVICES
6.3.1 SEQUENCING SERVICES
6.3.1.1 RNA SEQUENCING
6.3.1.2 DNA SEQUENCING
6.3.1.2.1 WHOLE GENOME SEQUENCING
6.3.1.2.2 WHOLE EXOME SEQUENCING
6.3.1.2.3 TARGETED SEQUENCING
6.3.1.2.4 CHIP SEQUENCING
6.3.1.2.5 DE NOVO SEQUENCING
6.3.1.2.6 OTHERS
6.3.2 DATA MANAGEMENT SERVICES
6.3.2.1 NGS STORAGE, MANAGEMENT AND CLOUD COMPUTING SOLUTIONS
6.3.2.2 NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES
6.3.2.3 NGS DATA ANALYSIS SERVICES
6.4 INSTRUMENTS
6.4.1 BENCHTOP
6.4.2 STANDALONE
6.4.2.1 AUTOMATED
6.4.2.2 SEMI-AUTOMATED
6.4.2.3 MANUAL
6.4.2.3.1 WORKSTATION/PLATFORM
6.4.2.3.2 SYSTEM
7 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 SEQUENCING BY SYNTHESIS (SBS)
7.2.1 PYROSEQUENCING
7.2.2 ION SEMI CONDUCTOR SEQUENCING
7.2.3 NANOPORE SEQUENCING
7.2.4 SINGLE-MOLECULE-REAL-TIME SEQUENCING (SMRT)
7.3 SEQUENCING BY LIGATION (SBL)
7.4 OTHERS
8 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 PHARMACEUTICALS MICROBIOLOGY
8.2.1 MICROBIAL IDENTIFICATION/DETECTION
8.2.2 TARGETED SEQUENCING
8.2.3 CELL LINE CHARACTERIZATION
8.2.4 ANTIMICROBIAL RESISTANCE AND PREDICTING ANTIMICROBIAL SUSCEPTIBILITIES
8.2.5 STRAIN SUBTYPING
8.2.6 OTHERS
8.2.6.1 SEQUENCING BY SYNTHESIS (SBS)
8.2.6.2 SEQUENCING BY LIGATION (SBL)
8.2.6.3 OTHERS
8.3 DRUG & BIOMARKER DISCOVERY
8.3.1 SEQUENCING BY SYNTHESIS (SBS)
8.3.2 SEQUENCING BY LIGATION (SBL)
8.3.3 OTHERS
8.4 DIAGNOSTICS
8.4.1 CANCER DIAGNOSTICS
8.4.2 INFECTIOUS DISEASE DIAGNOSTICS
8.4.3 REPRODUCTIVE HEALTH DIAGNOSTICS
8.4.4 OTHER DIAGNOSTIC APPLICATIONS
8.4.4.1 SEQUENCING BY SYNTHESIS (SBS)
8.4.4.2 SEQUENCING BY LIGATION (SBL)
8.4.5 OTHERS
8.5 PRECISION MEDICINE
8.5.1 SEQUENCING BY SYNTHESIS (SBS)
8.5.2 SEQUENCING BY LIGATION (SBL)
8.5.3 OTHERS
8.6 AGRICULTURAL & ANIMAL RESEARCH
8.6.1 SEQUENCING BY SYNTHESIS (SBS)
8.6.2 SEQUENCING BY LIGATION (SBL)
8.6.3 OTHERS
8.7 FOOD PATHOGEN SCREENING
8.8 OTHERS
9 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER
9.1 OVERVIEW
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.3 ACADEMIC & RESEARCH INSTITUTES
9.4 HOSPITALS & CLINICS
9.5 CLINICAL LABORATORIES
9.6 CONTRACT RESEARCH ORGANIZATIONS (CROS)
9.7 OTHERS
10 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT TENDER
10.3 RETAIL SALES
10.3.1 OFFLINE
10.3.2 ONLINE
10.4 OTHERS
11 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION
11.1 OVERVIEW
11.2 NORTH AMERICA
11.2.1 U.S.
11.2.2 CANADA
11.2.3 MEXICO
11.3 EUROPE
11.3.1 U.K.
11.3.2 GERMANY
11.3.3 FRANCE
11.3.4 SPAIN
11.3.5 ITALY
11.3.6 BELGIUM
11.3.7 RUSSIA
11.3.8 SWITZERLAND
11.3.9 NETHERLANDS
11.3.10 TURKEY
11.3.11 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 CHINA
11.4.2 AUSTRALIA
11.4.3 JAPAN
11.4.4 INDIA
11.4.5 SINGAPORE
11.4.6 SOUTH KOREA
11.4.7 MALAYSIA
11.4.8 THAILAND
11.4.9 INDONESIA
11.4.10 PHILIPPINES
11.4.11 REST OF ASIA-PACIFIC
11.5 SOUTH AMERICA
11.5.1 BRAZIL
11.5.2 ARGENTINA
11.5.3 REST OF SOUTH AMERICA
11.6 MIDDLE EAST AND AFRICA
11.6.1 SOUTH AFRICA
11.6.2 SAUDI ARABIA
11.6.3 U.A.E.
11.6.4 ISRAEL
11.6.5 REST OF MIDDLE EAST AND AFRICA
12 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: GLOBAL
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
12.3 COMPANY SHARE ANALYSIS: EUROPE
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
13 SWOT ANALYSIS
14 COMPANY PROFILING
14.1 ILLUMINA, INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUEANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 THERMO FISHER SCIENTIFIC INC.
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 QIAGEN
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 MERCK KGAA
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENT
14.5 CHARLES RIVER LABORATORIES
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 ACT GENOMICS
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENTS
14.7 AGILENT TECHNOLOGIES, INC.
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENT
14.8 AZENTA US, INC.
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENT
14.9 BECKMAN COULTER, INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 BIO-RAD LABORATORIES, INC.
14.10.1 COMPANY SNAPSHOT
14.10.2 REVENUE ANALYSIS
14.10.3 PRODUCT PORTFOLIO
14.10.4 RECENT DEVELOPMENTS
14.11 BGI (A SUBSIDIAIRY OF BGI GROUP) (2024)
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 DNASTAR
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENT
14.13 EUROFINS SCIENTIFIC
14.13.1 COMPANY SNAPSHOT
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPMENTS
14.14 GILSON INCORPORATED
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 HAMILTON COMPANY
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENT
14.16 LGC BIOSEARCH TECHNOLOGIES
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
14.17 MACROGEN, INC.
14.17.1 COMPANY SNAPSHOT
14.17.2 REVENUE ANALYSIS
14.17.3 PRODUCT PORTFOLIO
14.17.4 RECENT DEVELOPMENT
14.18 NEW ENGLAND BIOLABS
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENT
14.19 NIMAGEN
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.2 OXFORD NANOPORE TECHNOLOGIES PLC.
14.20.1 COMPANY SNAPSHOT
14.20.2 REVENUE ANALYSIS
14.20.3 PRODUCT PORTFOLIO
14.20.4 RECENT DEVELOPMENTS
14.21 PACBIO.
14.21.1 COMPANY SNAPSHOT
14.21.2 REVENUE ANALYSIS
14.21.3 PRODUCT PORTFOLIO
14.21.4 RECENT DEVELOPMENTS
14.22 PCR BIOSYSTEMS
14.22.1 COMPANY SNAPSHOT
14.22.2 PRODUCT PORTFOLIO
14.22.3 RECENT DEVELOPMENTS
14.23 PROMEGA CORPORATION.
14.23.1 COMPANY SNAPSHOT
14.23.2 PRODUCT PORTFOLIO
14.23.3 RECENT DEVELOPMENTS
14.24 QUANTABIO
14.24.1 COMPANY SNAPSHOT
14.24.2 PRODUCT PORTFOLIO
14.24.3 RECENT DEVELOPMENT
14.25 REVVITY
14.25.1 COMPANY SNAPSHOT
14.25.2 REVENUE ANALYSIS
14.25.3 PRODUCT PORTFOLIO
14.25.4 RECENT DEVELOPMENT
14.26 TAKARA BIO INC.
14.26.1 COMPANY SNAPSHOT
14.26.2 REVENUE ANALYSIS
14.26.3 PRODUCT PORTFOLIO
14.26.4 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
表のリスト
TABLE 1 INSTRUMENT COST PER RUN
TABLE 2 PLATFORM /COMPANY COST PER RUN
TABLE 3 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 4 GLOBAL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 5 GLOBAL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 6 GLOBAL SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 7 GLOBAL SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 8 GLOBAL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 9 GLOBAL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 10 GLOBAL DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 11 GLOBAL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 12 GLOBAL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 13 GLOBAL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 14 GLOBAL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 15 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 16 GLOBAL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 17 GLOBAL SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 18 GLOBAL SEQUENCING BY LIGATION (SBL) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 19 GLOBAL OTHERS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 20 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 21 GLOBAL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 22 GLOBAL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 23 GLOBAL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 24 GLOBAL DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 25 GLOBAL DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 26 GLOBAL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 27 GLOBAL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 28 GLOBAL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 29 GLOBAL PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 30 GLOBAL PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 31 GLOBAL AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 32 GLOBAL AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 33 GLOBAL FOOD PATHOGEN SCREENING IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 34 GLOBAL OTHERS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 35 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 36 GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 37 GLOBAL ACADEMIC & RESEARCH INSTITUTES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 38 GLOBAL HOSPITALS & CLINICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 39 GLOBAL CLINICAL LABORATORIES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 40 GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 41 GLOBAL OTHERS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 42 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 43 GLOBAL DIRECT TENDER IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 44 GLOBAL RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 45 GLOBAL RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 46 GLOBAL OTHERS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 47 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 48 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 49 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 50 NORTH AMERICA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 51 NORTH AMERICA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 52 NORTH AMERICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 53 NORTH AMERICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 54 NORTH AMERICA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 55 NORTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 56 NORTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 57 NORTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 58 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 59 NORTH AMERICA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 60 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 61 NORTH AMERICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 62 NORTH AMERICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 63 NORTH AMERICA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 64 NORTH AMERICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 65 NORTH AMERICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 66 NORTH AMERICA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 67 NORTH AMERICA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 68 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 69 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 70 NORTH AMERICA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 71 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 72 U.S. CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 73 U.S. SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 74 U.S. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 75 U.S. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 76 U.S. DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 77 U.S. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 78 U.S. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 79 U.S. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 80 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 81 U.S. SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 82 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 83 U.S. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 84 U.S. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 85 U.S. DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 86 U.S. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 87 U.S. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 88 U.S. PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 89 U.S. AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 90 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 91 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 92 U.S. RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 93 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 94 CANADA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 95 CANADA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 96 CANADA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 97 CANADA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 98 CANADA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 99 CANADA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 100 CANADA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 101 CANADA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 102 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 103 CANADA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 104 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 105 CANADA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 106 CANADA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 107 CANADA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 108 CANADA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 109 CANADA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 110 CANADA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 111 CANADA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 112 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 113 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 114 CANADA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 115 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 116 MEXICO CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 117 MEXICO SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 118 MEXICO SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 119 MEXICO SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 120 MEXICO DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 121 MEXICO INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 122 MEXICO INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 123 MEXICO INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 124 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 125 MEXICO SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 126 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 127 MEXICO PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 128 MEXICO PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 129 MEXICO DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 130 MEXICO DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 131 MEXICO DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 132 MEXICO PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 133 MEXICO AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 134 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 135 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 136 MEXICO RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 137 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 138 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 139 EUROPE CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 140 EUROPE SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 141 EUROPE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 142 EUROPE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 143 EUROPE DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 144 EUROPE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 145 EUROPE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 146 EUROPE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 147 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 148 EUROPE SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 149 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 150 EUROPE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 151 EUROPE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 152 EUROPE DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 153 EUROPE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 154 EUROPE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 155 EUROPE PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 156 EUROPE AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 157 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 158 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 159 EUROPE RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 160 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 161 U.K. CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 162 U.K. SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 163 U.K. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 164 U.K. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 165 U.K. DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 166 U.K. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 167 U.K. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 168 U.K. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 169 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 170 U.K. SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 171 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 172 U.K. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 173 U.K. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 174 U.K. DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 175 U.K. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 176 U.K. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 177 U.K. PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 178 U.K. AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 179 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 180 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 181 U.K. RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 182 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 183 GERMANY CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 184 GERMANY SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 185 GERMANY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 186 GERMANY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 187 GERMANY DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 188 GERMANY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 189 GERMANY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 190 GERMANY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 191 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 192 GERMANY SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 193 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 194 GERMANY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 195 GERMANY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 196 GERMANY DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 197 GERMANY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 198 GERMANY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 199 GERMANY PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 200 GERMANY AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 201 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 202 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 203 GERMANY RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 204 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 205 FRANCE CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 206 FRANCE SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 207 FRANCE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 208 FRANCE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 209 FRANCE DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 210 FRANCE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 211 FRANCE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 212 FRANCE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 213 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 214 FRANCE SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 215 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 216 FRANCE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 217 FRANCE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 218 FRANCE DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 219 FRANCE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 220 FRANCE PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 221 FRANCE AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 222 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 223 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 224 FRANCE RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 225 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 226 SPAIN CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 227 SPAIN SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 228 SPAIN SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 229 SPAIN SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 230 SPAIN DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 231 SPAIN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 232 SPAIN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 233 SPAIN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 234 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 235 SPAIN SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 236 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 237 SPAIN PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 238 SPAIN PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 239 SPAIN DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 240 SPAIN DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 241 SPAIN DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 242 SPAIN PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 243 SPAIN AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 244 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 245 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 246 SPAIN RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 247 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 248 ITALY CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 249 ITALY SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 250 ITALY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 251 ITALY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 252 ITALY DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 253 ITALY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 254 ITALY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 255 ITALY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 256 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 257 ITALY SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 258 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 259 ITALY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 260 ITALY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 261 ITALY DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 262 ITALY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 263 ITALY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 264 ITALY PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 265 ITALY AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 266 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 267 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 268 ITALY RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 269 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 270 BELGIUM CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 271 BELGIUM SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 272 BELGIUM SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 273 BELGIUM SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 274 BELGIUM DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 275 BELGIUM INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 276 BELGIUM INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 277 BELGIUM INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 278 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 279 BELGIUM SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 280 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 281 BELGIUM PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 282 BELGIUM PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 283 BELGIUM DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 284 BELGIUM DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 285 BELGIUM DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 286 BELGIUM PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 287 BELGIUM AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 288 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 289 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 290 BELGIUM RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 291 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 292 RUSSIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 293 RUSSIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 294 RUSSIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 295 RUSSIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 296 RUSSIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 297 RUSSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 298 RUSSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 299 RUSSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 300 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 301 RUSSIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 302 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 303 RUSSIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 304 RUSSIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 305 RUSSIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 306 RUSSIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 307 RUSSIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 308 RUSSIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 309 RUSSIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 310 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 311 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 312 RUSSIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 313 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 314 SWITZERLAND CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 315 SWITZERLAND SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 316 SWITZERLAND SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 317 SWITZERLAND SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 318 SWITZERLAND DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 319 SWITZERLAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 320 SWITZERLAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 321 SWITZERLAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 322 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 323 SWITZERLAND SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 324 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 325 SWITZERLAND PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 326 SWITZERLAND PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 327 SWITZERLAND DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 328 SWITZERLAND DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 329 SWITZERLAND DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 330 SWITZERLAND PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 331 SWITZERLAND AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 332 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 333 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 334 SWITZERLAND RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 335 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 336 NETHERLANDS CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 337 NETHERLANDS SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 338 NETHERLANDS SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 339 NETHERLANDS SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 340 NETHERLANDS DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 341 NETHERLANDS INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 342 NETHERLANDS INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 343 NETHERLANDS INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 344 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 345 NETHERLANDS SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 346 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 347 NETHERLANDS PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 348 NETHERLANDS PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 349 NETHERLANDS DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 350 NETHERLANDS DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 351 NETHERLANDS DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 352 NETHERLANDS PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 353 NETHERLANDS AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 354 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 355 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 356 NETHERLANDS RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 357 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 358 TURKEY CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 359 TURKEY SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 360 TURKEY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 361 TURKEY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 362 TURKEY DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 363 TURKEY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 364 TURKEY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 365 TURKEY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 366 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 367 TURKEY SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 368 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 369 TURKEY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 370 TURKEY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 371 TURKEY DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 372 TURKEY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 373 TURKEY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 374 TURKEY PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 375 TURKEY AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 376 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 377 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 378 TURKEY RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 379 REST OF EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 380 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 381 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 382 ASIA-PACIFIC CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 383 ASIA-PACIFIC SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 384 ASIA-PACIFIC SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 385 ASIA-PACIFIC SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 386 ASIA-PACIFIC DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 387 ASIA-PACIFIC INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 388 ASIA-PACIFIC INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 389 ASIA-PACIFIC INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 390 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 391 ASIA-PACIFIC SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 392 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 393 ASIA-PACIFIC PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 394 ASIA-PACIFIC PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 395 ASIA-PACIFIC DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 396 ASIA-PACIFIC DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 397 ASIA-PACIFIC DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 398 ASIA-PACIFIC PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 399 ASIA-PACIFIC AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 400 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 401 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 402 ASIA-PACIFIC RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 403 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 404 CHINA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 405 CHINA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 406 CHINA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 407 CHINA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 408 CHINA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 409 CHINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 410 CHINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 411 CHINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 412 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 413 CHINA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 414 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 415 CHINA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 416 CHINA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 417 CHINA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 418 CHINA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 419 CHINA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 420 CHINA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 421 CHINA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 422 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 423 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 424 CHINA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 425 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 426 AUSTRALIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 427 AUSTRALIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 428 AUSTRALIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 429 AUSTRALIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 430 AUSTRALIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 431 AUSTRALIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 432 AUSTRALIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 433 AUSTRALIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 434 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 435 AUSTRALIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 436 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 437 AUSTRALIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 438 AUSTRALIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 439 AUSTRALIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 440 AUSTRALIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 441 AUSTRALIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 442 AUSTRALIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 443 AUSTRALIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 444 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 445 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 446 AUSTRALIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 447 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 448 JAPAN CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 449 JAPAN SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 450 JAPAN SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 451 JAPAN SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 452 JAPAN DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 453 JAPAN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 454 JAPAN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 455 JAPAN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 456 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 457 JAPAN SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 458 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 459 JAPAN PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 460 JAPAN PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 461 JAPAN DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 462 JAPAN DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 463 JAPAN DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 464 JAPAN PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 465 JAPAN AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 466 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 467 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 468 JAPAN RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 469 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 470 INDIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 471 INDIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 472 INDIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 473 INDIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 474 INDIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 475 INDIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 476 INDIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 477 INDIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 478 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 479 INDIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 480 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 481 INDIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 482 INDIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 483 INDIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 484 INDIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 485 INDIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 486 INDIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 487 INDIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 488 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 489 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 490 INDIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 491 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 492 SINGAPORE CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 493 SINGAPORE SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 494 SINGAPORE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 495 SINGAPORE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 496 SINGAPORE DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 497 SINGAPORE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 498 SINGAPORE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 499 SINGAPORE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 500 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 501 SINGAPORE SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 502 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 503 SINGAPORE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 504 SINGAPORE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 505 SINGAPORE DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 506 SINGAPORE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 507 SINGAPORE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 508 SINGAPORE PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 509 SINGAPORE AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 510 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 511 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 512 SINGAPORE RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 513 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 514 SOUTH KOREA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 515 SOUTH KOREA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 516 SOUTH KOREA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 517 SOUTH KOREA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 518 SOUTH KOREA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 519 SOUTH KOREA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 520 SOUTH KOREA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 521 SOUTH KOREA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 522 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 523 SOUTH KOREA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 524 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 525 SOUTH KOREA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 526 SOUTH KOREA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 527 SOUTH KOREA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 528 SOUTH KOREA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 529 SOUTH KOREA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 530 SOUTH KOREA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 531 SOUTH KOREA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 532 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 533 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 534 SOUTH KOREA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 535 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 536 MALAYSIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 537 MALAYSIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 538 MALAYSIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 539 MALAYSIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 540 MALAYSIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 541 MALAYSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 542 MALAYSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 543 MALAYSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 544 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 545 MALAYSIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 546 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 547 MALAYSIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 548 MALAYSIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 549 MALAYSIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 550 MALAYSIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 551 MALAYSIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 552 MALAYSIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 553 MALAYSIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 554 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 555 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 556 MALAYSIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 557 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 558 THAILAND CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 559 THAILAND SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 560 THAILAND SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 561 THAILAND SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 562 THAILAND DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 563 THAILAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 564 THAILAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 565 THAILAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 566 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 567 THAILAND SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 568 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 569 THAILAND PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 570 THAILAND PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 571 THAILAND DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 572 THAILAND DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 573 THAILAND DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 574 THAILAND PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 575 THAILAND AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 576 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 577 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 578 THAILAND RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 579 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 580 INDONESIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 581 INDONESIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 582 INDONESIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 583 INDONESIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 584 INDONESIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 585 INDONESIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 586 INDONESIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 587 INDONESIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 588 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 589 INDONESIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 590 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 591 INDONESIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 592 INDONESIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 593 INDONESIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 594 INDONESIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 595 INDONESIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 596 INDONESIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 597 INDONESIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 598 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 599 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 600 INDONESIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 601 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 602 PHILIPPINES CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 603 PHILIPPINES SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 604 PHILIPPINES SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 605 PHILIPPINES SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 606 PHILIPPINES DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 607 PHILIPPINES INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 608 PHILIPPINES INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 609 PHILIPPINES INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 610 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 611 PHILIPPINES SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 612 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 613 PHILIPPINES PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 614 PHILIPPINES PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 615 PHILIPPINES DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 616 PHILIPPINES DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 617 PHILIPPINES DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 618 PHILIPPINES PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 619 PHILIPPINES AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 620 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 621 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 622 PHILIPPINES RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 623 REST OF ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 624 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 625 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 626 SOUTH AMERICA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 627 SOUTH AMERICA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 628 SOUTH AMERICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 629 SOUTH AMERICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 630 SOUTH AMERICA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 631 SOUTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 632 SOUTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 633 SOUTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 634 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 635 SOUTH AMERICA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 636 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 637 SOUTH AMERICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 638 SOUTH AMERICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 639 SOUTH AMERICA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 640 SOUTH AMERICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 641 SOUTH AMERICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 642 SOUTH AMERICA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 643 SOUTH AMERICA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 644 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 645 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 646 SOUTH AMERICA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 647 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 648 BRAZIL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 649 BRAZIL SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 650 BRAZIL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 651 BRAZIL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 652 BRAZIL DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 653 BRAZIL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 654 BRAZIL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 655 BRAZIL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 656 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 657 BRAZIL SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 658 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 659 BRAZIL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 660 BRAZIL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 661 BRAZIL DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 662 BRAZIL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 663 BRAZIL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 664 BRAZIL PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 665 BRAZIL AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 666 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 667 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 668 BRAZIL RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 669 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 670 ARGENTINA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 671 ARGENTINA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 672 ARGENTINA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 673 ARGENTINA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 674 ARGENTINA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 675 ARGENTINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 676 ARGENTINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 677 ARGENTINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 678 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 679 ARGENTINA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 680 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 681 ARGENTINA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 682 ARGENTINA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 683 ARGENTINA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 684 ARGENTINA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 685 ARGENTINA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 686 ARGENTINA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 687 ARGENTINA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 688 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 689 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 690 ARGENTINA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 691 REST OF SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 692 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 693 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 694 MIDDLE EAST & AFRICA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 695 MIDDLE EAST & AFRICA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 696 MIDDLE EAST & AFRICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 697 MIDDLE EAST & AFRICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 698 MIDDLE EAST & AFRICA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 699 MIDDLE EAST & AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 700 MIDDLE EAST & AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 701 MIDDLE EAST & AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 702 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 703 MIDDLE EAST & AFRICA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 704 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 705 MIDDLE EAST & AFRICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 706 MIDDLE EAST & AFRICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 707 MIDDLE EAST & AFRICA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 708 MIDDLE EAST & AFRICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 709 MIDDLE EAST & AFRICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 710 MIDDLE EAST & AFRICA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 711 MIDDLE EAST & AFRICA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 712 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 713 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 714 MIDDLE EAST & AFRICA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 715 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 716 SOUTH AFRICA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 717 SOUTH AFRICA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 718 SOUTH AFRICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 719 SOUTH AFRICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 720 SOUTH AFRICA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 721 SOUTH AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 722 SOUTH AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 723 SOUTH AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 724 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 725 SOUTH AFRICA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 726 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 727 SOUTH AFRICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 728 SOUTH AFRICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 729 SOUTH AFRICA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 730 SOUTH AFRICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 731 SOUTH AFRICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 732 SOUTH AFRICA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 733 SOUTH AFRICA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 734 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 735 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 736 SOUTH AFRICA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 737 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 738 SAUDI ARABIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 739 SAUDI ARABIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 740 SAUDI ARABIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 741 SAUDI ARABIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 742 SAUDI ARABIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 743 SAUDI ARABIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 744 SAUDI ARABIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 745 SAUDI ARABIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 746 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 747 SAUDI ARABIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 748 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 749 SAUDI ARABIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 750 SAUDI ARABIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 751 SAUDI ARABIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 752 SAUDI ARABIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 753 SAUDI ARABIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 754 SAUDI ARABIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 755 SAUDI ARABIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 756 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 757 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 758 SAUDI ARABIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 759 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 760 U.A.E. CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 761 U.A.E. SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 762 U.A.E. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 763 U.A.E. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 764 U.A.E. DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 765 U.A.E. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 766 U.A.E. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 767 U.A.E. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 768 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 769 U.A.E. SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 770 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 771 U.A.E. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 772 U.A.E. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 773 U.A.E. DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 774 U.A.E. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 775 U.A.E. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 776 U.A.E. PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 777 U.A.E. AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 778 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 779 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 780 U.A.E. RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 781 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 782 EGYPT CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 783 EGYPT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 784 EGYPT SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 785 EGYPT SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 786 EGYPT DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 787 EGYPT INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 788 EGYPT INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 789 EGYPT INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 790 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 791 EGYPT SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 792 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 793 EGYPT PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 794 EGYPT PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 795 EGYPT DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 796 EGYPT DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 797 EGYPT DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 798 EGYPT PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 799 EGYPT AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 800 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 801 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 802 EGYPT RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 803 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 804 ISRAEL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 805 ISRAEL SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 806 ISRAEL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 807 ISRAEL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 808 ISRAEL DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 809 ISRAEL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 810 ISRAEL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 811 ISRAEL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 812 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 813 ISRAEL SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 814 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 815 ISRAEL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 816 ISRAEL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 817 ISRAEL DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 818 ISRAEL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 819 ISRAEL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 820 ISRAEL PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 821 ISRAEL AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 822 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 823 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 824 ISRAEL RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 825 REST OF MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
図表一覧
FIGURE 1 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: SEGMENTATION
FIGURE 2 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: SEGMENTATION
FIGURE 11 INCREASING ADOPTION OF NGS-BASED TESTS IN ONCOLOGY, PRENATAL SCREENING, AND INFECTIOUS DISEASE SURVEILLANCE IS DRIVING THE GROWTH OF THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET FROM 2024 TO 2031
FIGURE 12 THE PRODUCT AND SERVICE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET IN 2024 AND 2031
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING REGION FOR NEXT GENERATION SEQUENCING (NGS) MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET
FIGURE 16 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY PRODUCT AND SERVICE 2023
FIGURE 17 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY PRODUCT AND SERVICES, 2024-2031 (USD MILLION)
FIGURE 18 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY PRODUCT AND SERVICE, CAGR (2024-2031)
FIGURE 19 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET BY PRODUCT AND SERVICE, LIFELINE CURVE
FIGURE 20 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY TECHNOLOGY 2023
FIGURE 21 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY TECHNOLOG, 2024-2031 (USD MILLION)
FIGURE 22 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY TECHNOLOG, CAGR (2024-2031)
FIGURE 23 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET BY TECHNOLOG, LIFELINE CURVE
FIGURE 24 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY APPLICATION, 2023
FIGURE 25 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY APPLICATION, 2024-2031 (USD MILLION)
FIGURE 26 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY APPLICATION, CAGR (2024-2031)
FIGURE 27 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY APPLICATION, LIFELINE CURVE
FIGURE 28 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY END USER, 2023
FIGURE 29 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY END USER, 2024-2031 (USD MILLION)
FIGURE 30 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY END USER, CAGR (2024-2031)
FIGURE 31 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY END USER, LIFELINE CURVE
FIGURE 32 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY DISTRIBUTION CHANNEL, 2023
FIGURE 33 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)
FIGURE 34 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 35 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 36 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: SNAPSHOT (2023)
FIGURE 37 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE 2023 (%)
FIGURE 38 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE 2023 (%)
FIGURE 39 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE 2023 (%)
FIGURE 40 AISA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE 2023 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
